MedTrace Logo

suPAR in the Early Diagnosis of Acute Kidney Injury(AKI) After On-Pump Cardiac Surgery

NCT02921113 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2017-09-08

No results posted yet for this study

Summary

Acute Kidney Injury(AKI) is of the serious complications in patients with undergoing on-pump cardiac surgery. End stage kidney failure requiring dialysis therapy after cardiac surgery is associated with more than 60% mortality rate. Involvement of AKI after on-pump cardiac surgery increases the mortality rate 19 times. suPAR is one of the novel biomarker which has potential prognostic value for renal dysfunction in patients with undergoing on-pump cardiac surgery. Early diagnosis and prompt intervention to prevent AKI has great importance for management of postoperative cardiac patients.

Conditions

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • Bünyamin KIR, M.D · Marmara University School of Medicine Dept of Anesthesiology and Reanimation

  • İsmail Cinel, Prof. M.D · Marmara University School of Medicine Dept of Anesthesiology and Reanimation

  • Beliz Bilgili, Asst. Prof. · Marmara University School of Medicine Dept. of Anesthesiology and Reanimation

  • Sinan Arsan, Prof. M.D · Marmara University School of Medicine Dept. of Cardiovascular Surgery

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-04-30
Completion
2017-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02921113 on ClinicalTrials.gov